Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechno... more
Publishes | Infrequently | Episodes | 22 | Founded | 2 years ago |
---|---|---|---|---|---|
Number of Listeners | Categories | Life SciencesHealth & FitnessMedicineScience |
In this special episode of Conversations in Drug Development, host Harriet Edwards sits down with Professor Alan Boyd, founder and CEO of Boyds, to reflect on the company’s remarkable 20-year journey in drug development.
Professor Boyd shares his ex... more
In the latest episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Eric Hardter discuss the ever-changing US regulatory landscape under the new administration, including new leadership and staff turnover, and their impact on drug d... more
In this episode, Dr Neil Fish and Dr Ami Patel dive into the real-world challenges of drug development - from early-stage planning to regulatory hurdles and everything in between. Drawing on decades of experience, they share personal stories and expe... more
In this episode, Harriet Edwards from Boyds hosts a discussion on 2025 predictions in drug development and regulatory affairs. Joined by regulatory experts Dr. Katherine Bowen and Dr. Eric Hartder, the conversation covers the anticipated trends in th... more
People also subscribe to these shows.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
Listeners per Episode | |
---|---|
Gender Skew | |
Location | |
Interests | |
Professions | |
Age Range | |
Household Income | |
Social Media Reach |
This podcast provides insightful discussions surrounding the complexities and innovations within the realms of drug development, particularly focusing on cell and gene therapies and regulatory affairs. Through engaging dialogues with industry experts, the content frequently addresses pivotal topics such as regulatory processes, clinical trials, and patient engagement in drug development, emphasizing the significance of keeping patients' voices at the forefront. Additionally, the series often explores the implications of new regulations, advanced therapeutic products, and collaborative efforts needed to shape the future of medical advancements. Unique to this offering is the blend of real-world insights from practitioners who are deeply entr... more
Rephonic provides a wide range of podcast stats for Conversations in Drug Development. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Conversations in Drug Development and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Conversations in Drug Development, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Conversations in Drug Development, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Conversations in Drug Development has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Conversations in Drug Development:
1. BioCentury This Week
2. The Readout Loud
3. Worklife with Adam Grant
4. Think Fast Talk Smart: Communication Techniques
5. NEJM This Week
Conversations in Drug Development launched 2 years ago and published 22 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Conversations in Drug Development from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Conversations in Drug Development. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on Conversations in Drug Development include:
1. Chris Moore
2. Katherine Bowen
3. Shalini Gupta
4. Monica Pianella
5. Dr. Sabine Ruehle
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.